Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.5510
-0.0333 (-5.70%)
At close: Jul 16, 2026

RVPH Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
22.1914.4413.4823.3718.5229.69
Cash & Short-Term Investments
22.1914.4413.4823.3718.5229.69
Cash Growth
319.52%7.14%-42.33%26.17%-37.62%238.89%
Other Current Assets
1.370.661.210.330.41.72
Total Current Assets
23.5615.114.6823.718.9231.4
Other Long-Term Assets
-0.820.82---
Total Assets
23.5615.9215.523.718.9231.4
Accounts Payable
2.093.016.283.853.520.51
Accrued Expenses
3.83.867.8613.336.441.84
Short-Term Debt
0.230.410.46---
Total Current Liabilities
6.127.2814.617.189.962.34
Other Long-Term Liabilities
--0.090.810.570.37
Total Long-Term Liabilities
--0.090.810.570.37
Total Liabilities
6.127.2814.6917.9810.532.72
Common Stock
0.010.010000
Additional Paid-in Capital
204.76192.77165.08140.07103.4995.52
Retained Earnings
-187.33-184.14-164.27-134.35-95.09-66.83
Shareholders' Equity
17.448.650.815.728.3928.69
Total Liabilities & Equity
23.5615.9215.523.718.9231.4
Total Debt
0.230.410.46000
Net Cash (Debt)
21.9614.0313.0223.3718.5229.69
Net Cash Growth
56.49%7.79%-44.29%26.17%-37.62%238.89%
Net Cash Per Share
4.603.877.7119.6418.9840.14
Book Value
17.448.650.815.728.3928.69
Book Value Per Share
3.652.380.484.818.6038.79
Tangible Book Value
17.448.650.815.728.3928.69
Tangible Book Value Per Share
3.652.380.484.818.6038.79